Evaluation of the prevention by actoplus/met (pioglitazone and metformin) of ER+ and ER- mammary cancers occurring in rodents on a high FAT diet
Ended Awarded Last action
- Contract number
- HHSN26100006
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $487,210
Award facts
- Contract value 100% obligated
- $487,210.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,883 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $489,093 |
Quick answers
Who was awarded contract HHSN26100006?
HHSN26100006 was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on August 26, 2014.
How much is contract HHSN26100006 worth?
The government has obligated $487,210 on HHSN26100006.
Is contract HHSN26100006 an order under another contract?
Yes. HHSN26100006 is a delivery order under HHSN261201200021I, an indefinite delivery contract, on Preclinical Agent Development Assays 2012-2016.
Was contract HHSN26100006 competed?
The extent of competition for HHSN26100006 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award